Neuroleptic malignant syndrome (NMS) is a rare neurological condition associated with the use of antipsychotic medications. Autonomic dysfunction, or damage to the nerves that control involuntary ...
Neuroleptic malignant syndrome (NMS) and serotonin syndrome (SS) are rare, potentially fatal reactions to certain medications that can appear alarmingly similar. Both can cause confusion, fever, and ...
NMS Capital has promoted Daniel Schwartz to managing director and Jake Kinsley to vice president. Schwartz joined NMS in 2021 as a principal while Kinsley came on board in 2018 as an associate. New ...
LOS ANGELES, CA / ACCESS Newswire / August 27, 2025 / NMS Capital Group ("NMS"), a leading family office backed private equity firm, today announced the launch of NMS Sports, a new division focused ...
New York, NY, October 22, 2019 – NMS Capital (“NMS”) announced today that it has exited its investment in ettain group, Inc. (“ettain” or the “Company”) through its sale to Alvarez & Marsal Capital ...
The US Securities and Exchange Commission (SEC) adopted amendments to Regulation National Market System (Regulation NMS or Reg NMS). Regulation NMS was adopted in 2005 to provide a comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results